Change between Phase 1 and Phase 2 | GHQ caseness by Phase 2 | GHQ caseness by Phase 3 | ||||
---|---|---|---|---|---|---|
n (cases) | Unadjusted OR (95% CI) | Adjusted* OR (95% CI) | n (cases) | Unadjusted OR (95% CI) | Adjusted* OR (95% CI) | |
*Adjusted for age, grade, and physical illness indicator (diabetes, diagnosed heart trouble, hypertension, ECG abnormalities, and/or respiratory illness) and relational justice at Phase 1. | ||||||
Women | 1684 (404) | 1464 (491) | ||||
Relational justice | ||||||
Favourable change | 383 (82) | 0.94 (0.71 to 1.26) | 0.74 (0.55 to 1.01) | 331 (114) | 1.18 (0.90 to 1.55) | 0.94 (0.70 to 1.26) |
No change | 964 (216) | 1.00 | 1.00 | 844 (260) | 1.00 | 1.00 |
Adverse change | 337 (106) | 1.59 (1.21 to 2.09) | 1.74 (1.31 to 2.30) | 289 (117) | 1.53 (1.16 to 2.01) | 1.68 (1.26 to 2.24) |
Test for linear trend | p < 0.0001 | p < 0.0001 | p = 0.02 | p < 0.0001 | ||
Men | 4016 (785) | 3622 (1008) | ||||
Relational justice | ||||||
Favourable change | 808 (144) | 0.98 (0.79 to 1.20) | 0.75 (0.60 to 0.94) | 728 (199) | 1.06 (0.87 to 1.27) | 0.86 (0.70 to 1.05) |
No change | 2471 (449) | 1.00 | 1.00 | 2246 (590) | 1.00 | 1.00 |
Adverse change | 737 (192) | 1.59 (1.31 to 1.93) | 1.81 (1.48 to 2.21) | 648 (219) | 1.43 (1.19 to 1.73) | 1.59 (1.31 to 1.93) |
Test for linear trend | p < 0.0001 | p < 0.0001 | p = 0.0003 | p < 0.0001 |